CircNova

Curated by Signal

AI-powered platform to analyze and identify circular RNA for therapeutic development

Overview

AI-powered platform to analyze and identify circular RNA for therapeutic development. The company uses AI NovaEngine to predict circular RNA structures using deep-learning, allowing therapeutic design for "undruggable" diseases, such as Triple-negative Breast Cancer.

Key facts

Founded: 2023
Headquarters: Detroit, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view

Open roles

2 roles

Lab Director, Wet Lab
Boston, MA · On-site · Volunteer
Senior Director / Director of Discovery
Detroit Metropolitan Area · On-site · Full-time

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Cerora
Provider of neuro diagnostics device & software platform
Health TechnologyBethlehem, United States
Pharmix
Provider of AI based computational drug design solutions
Health TechnologySan Francisco, United States
BBK Worldwide
Software solutions and consulting services for patient recruitment and retention services
Health TechnologyNeedham, United States

About CircNova

What does CircNova do?

AI-powered platform to analyze and identify circular RNA for therapeutic development.

Where is CircNova headquartered?

CircNova is headquartered in Detroit, United States.

When was CircNova founded?

CircNova was founded in 2023.

Which sector is CircNova in?

CircNova operates in Health Technology.

Who are CircNova's competitors?

Companies similar to CircNova include Cerora, Pharmix, and BBK Worldwide.

Is CircNova hiring?

Yes. CircNova has 2 open roles listed on Vanberra Signal.